Indication
Locally advanced breast carcinoma
Locally advanced breast carcinoma refers to an aggressive, invasive epithelial malignancy arising within breast glandular tissue that exhibits extensive locoregional extension without evidence of distant metastasis. Read more about Locally advanced breast carcinoma
98 drugs 61 manufacturers
Drugs that treat it
Common Locally advanced breast carcinoma therapies.
DOXORUBICIN HCL
DOXORUBICIN HCL
PACLITAXEL
PACLITAXEL
PACLITAXEL
DOXORUBICIN HCL
EPIRUBICIN HCL
DOCETAXEL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonLocally advanced breast carcinoma refers to an aggressive, invasive epithelial malignancy arising within breast glandular tissue that exhibits extensive locoregional extension without evidence of distant metastasis.
Primarily affecting adult women, it encompasses AJCC stage III disease (including stages IIIA, IIIB, and IIIC) and select high-risk stage IIB presentations.
Defining clinicopathologic features include primary tumors exceeding 5 centimeters, extensive direct invasion into the overlying skin or underlying chest wall, inflammatory breast carcinoma morphology, or heavy regional nodal involvement such as matted axillary, internal mammary, or supraclavicular lymphadenopathy.
- cancer.gov
Locally advanced breast carcinoma refers to an aggressive, invasive epithelial malignancy arising within breast glandular tissue that exhibits extensive locoregional extension without evidence of distant metastasis Primarily affecting adult women, it encompasses AJCC stage III disease (including stages IIIA, IIIB, and IIIC) and select high-risk stage IIB presentations
- nih.gov
Locally advanced breast carcinoma refers to an aggressive, invasive epithelial malignancy arising within breast glandular tissue that exhibits extensive locoregional extension without evidence of distant metastasis Primarily affecting adult women, it encompasses AJCC stage III disease (including stages IIIA, IIIB, and IIIC) and select high-risk stage IIB presentations Defining clinicopathologic features include primary tumors exceeding 5 centimeters, extensive direct invasion into the overlying ...
- nih.gov
Locally advanced breast carcinoma refers to an aggressive, invasive epithelial malignancy arising within breast glandular tissue that exhibits extensive locoregional extension without evidence of distant metastasis
- nih.gov
Primarily affecting adult women, it encompasses AJCC stage III disease (including stages IIIA, IIIB, and IIIC) and select high-risk stage IIB presentations
- cancer.gov
Defining clinicopathologic features include primary tumors exceeding 5 centimeters, extensive direct invasion into the overlying skin or underlying chest wall, inflammatory breast carcinoma morphology, or heavy regional nodal involvement such as matted axillary, internal mammary, or supraclavicular lymphadenopathy
- nih.gov
Defining clinicopathologic features include primary tumors exceeding 5 centimeters, extensive direct invasion into the overlying skin or underlying chest wall, inflammatory breast carcinoma morphology, or heavy regional nodal involvement such as matted axillary, internal mammary, or supraclavicular lymphadenopathy
Personalize your experience
Follow Locally advanced breast carcinoma and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.